DA 5213
Alternative Names: DA-5213Latest Information Update: 19 Nov 2021
At a glance
- Originator Dong-A ST
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 10 Nov 2021 Preclinical trials in Unspecified in South Korea (PO)
- 03 Nov 2021 Dong-A ST plans a phase I pharmacokinetics and safety trial (in volunteers) in South Korea (NCT05106205)